Showing 101 - 120 results of 144 for search '"drug interaction"', query time: 0.06s Refine Results
  1. 101

    HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART by Caron A. Jacobson, Jeremy S. Abramson

    Published 2012-01-01
    “…Despite these significant advances, HIV-HL patients remain at increased risk for treatment-related toxicities and drug-drug interactions which require careful attention and supportive care to insure the safe administration of therapy. …”
    Get full text
    Article
  2. 102

    Glutamate Receptors in Neuroinflammatory Demyelinating Disease

    Published 2006-01-01
    “…However, over the past decade, a group of compounds that suppress EAE but have no apparent immunomodulatory activity have emerged. These drugs interact with the N-methyl-D-aspartate (NMDA) and <mml:math alttext="$alpha$"><mml:mi>&#x03B1;</mml:mi> </mml:math>-amino-3-hydroxy-5-isoxazolepropionic acid (AMPA)/kainate family of glutamate receptors reported to control neurovascular permeability, inflammatory mediator synthesis, and resident glial cell functions including CNS myelination. …”
    Get full text
    Article
  3. 103

    Tacrolimus toxicity management in a pregnant kidney transplant recipient with newly diagnosed human immunodeficiency virus: A case report by Ahmad Matarneh, Ravi chokshi, Sundus Sardar, Dinia Salmeron, James O’brien, Fareeha Khalil, Naman Trivedi, Nasrollah Ghahramani, Vaqar Shah

    Published 2025-02-01
    “…Notably, tacrolimus is highly susceptible to drug-drug interactions. Even minor adjustments in highly active antiretroviral therapy can result in significant fluctuations in tacrolimus levels, potentially leading to subtherapeutic concentrations (increasing the risk of rejection) or supratherapeutic levels with toxicity. …”
    Get full text
    Article
  4. 104

    Inflammation, impaired motor function and visceral hypersensitivity: the main mechanisms of functional disorders of the gastrointestinal tract (materials of the Expert Council and... by V. T. Ivashkin, I. V. Maev, A. S. Trukhmanov, A. A. Sheptulin, T. L. Lapina, V. I. Simanenkov, K. A. Sokolov

    Published 2022-05-01
    “…This often leads to the prescription of a complex of various medications to such patients, which increases the risk of undesirable drug interactions and side effects. Multitargeted therapy involves the use of drugs that simultaneously affect different pathogenetic links. …”
    Get full text
    Article
  5. 105

    New Prospective for the Management of Low-Risk Pulmonary Embolism: Prognostic Assessment, Early Discharge, and Single-Drug Therapy with New Oral Anticoagulants by Alessandro Squizzato

    Published 2012-01-01
    “…Oral administration, predictable anticoagulant responses, and few drug-drug interactions of direct thrombin and factor Xa inhibitors may further simplify PE home therapy avoiding administration of low-molecular-weight heparin.…”
    Get full text
    Article
  6. 106

    Herbal Use among Presurgical Patients in Turkey: A Cross-Sectional Study by Fulya Yilmaz, Hazal Ezgi Çifci

    Published 2018-01-01
    “…Anesthesiologist should be aware of the effects of herbals on body functions and possible herbal-drug interactions to take care of such potentional perioperative complications.…”
    Get full text
    Article
  7. 107
  8. 108
  9. 109

    Heart rhythm disorders and features of their management at COVID-19 pandemic by Yu.M. Mostovoy, T.D. Danilevych

    Published 2021-10-01
    “…In addition, there are controversial questions about the features of their management, drug interactions, routing and prognosis of the patients. …”
    Get full text
    Article
  10. 110

    Theoretical Calculations and Molecular Docking Analysis of 4-(2-(4-Bromophenyl)Hydrazineylidene)-3,5-Diphenyl-4H-Pyrazole Molecule by Ümit Yıldıko, Veysel Tahiroğlu, Mehmet Bağlan, Kenan Gören

    Published 2024-12-01
    “…Many possible drugs for treating various medical diseases have taken their place in the world market. Drug interactions involve combinations with drugs or other substances that change the effect of a drug on the body. …”
    Get full text
    Article
  11. 111
  12. 112

    The Effect of the Thai Herbal Suksaiyad Formula on Platelet Aggregation in Healthy Volunteers: A Quasi-experimental, Single-dose Study by Titchaphorn Palo, Nalinthika Nathananwanit, Pravit Akarasereenont, Suksalin Booranasubkajorn

    Published 2025-02-01
    “…Conclusion: Caution is advised when using SSF in patients with blood disorders. Potential herb-drug interactions between SSF and drugs that impact platelet aggregation, such as aspirin, should be closely monitored. …”
    Get full text
    Article
  13. 113
  14. 114

    Interprofessional approach to personalized medication management and therapy optimization in IBD care by Daniel Fleischmann, Benedicta Binder, Muriel Huss, Tanja Elger, Claudia Wolf, Johanna Loibl, Hauke Christian Tews, Arne Kandulski, Stephan Schmid, Martina Müller, Alexander Kratzer

    Published 2025-01-01
    “…A considerable number of patients with chronic inflammatory bowel diseases (IBD) are required to manage extensive polypharmaceutical regimes, which significantly elevates the risk of drug–drug interactions. Also, the disease’s impact often leads to the consumption of additional self-medication by the patients such as naturopathic remedies to alleviate disease-induced suffering and nutritional supplements to compensate for malabsorption syndromes inherent to the condition. …”
    Get full text
    Article
  15. 115

    Self-Medication among Medical and Nonmedical Students at the University of Gondar, Northwest Ethiopia: A Cross-Sectional Study by Zelalem T. Tesfaye, Asrat E. Ergena, Bilal T. Yimer

    Published 2020-01-01
    “…Despite having some benefits, self-medication increases risks such as unnecessary use of medication, extended duration of consumption, incorrect diagnosis, drug-drug interactions, and polypharmacy. Thus, the purpose of this study is to compare self-medication practice between medical and nonmedical students of the University of Gondar, Northwest Ethiopia. …”
    Get full text
    Article
  16. 116

    The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and Mycobacterium abscessus pulmonary disease by Claire Y Mou, Daniel J Henderson, Angela G Matson, Karen M Herd, David W Reid, Timothy Riddles, Ellie Johnson, Brett McWhinney, Rebecca Swenson, Andrew Burke, Ieuan E S Evans

    Published 2025-12-01
    “…This case highlights the challenges surrounding ETI TDM in the context of acute severe illness, malnutrition, chronic infection, and drug-to-drug interactions. The marked clinical improvement seen, alongside sustained ETI plasma concentrations and suppressed sweat chloride levels on serial testing, provided reassurance of the use of ETI and rifabutin concomitantly in this case, and highlights the potential utility of TDM in helping guide clinical practice. …”
    Get full text
    Article
  17. 117

    Polypharmacy in Patients with Type 2 Diabetes and Arterial Hypertension Treated in a Provincial Hospital by José Ander Asenjo Alarcón

    Published 2022-11-01
    “…This use increases the longer they have been since their diagnosis, a situation that can have a negative impact on the health of patients due to drug interactions. <strong><br />Objective</strong>: to associate polypharmacy with the main chronic diseases in patients treated in a Peruvian provincial hospital. …”
    Get full text
    Article
  18. 118

    Human microbiome, applied to clinical practice by V. T. Ivashkin, K. V. Ivashkin

    Published 2018-08-01
    “…There is a need to study of possible effects of altered microbiome on drug interactions and the immune status. The model of bacterial involvement in colorectal cancer progression is under study. …”
    Get full text
    Article
  19. 119

    Cardiovascular manifestations in COVID-19 patients by Jyotsna Maddury, Mani Krishna, Achukatla Kumar

    Published 2022-01-01
    “…Consideration for potential drug interactions should be taken when treating CVD patients with COVID-19.…”
    Get full text
    Article
  20. 120

    Telaprevir in treatment of chronic hepatitis C: safety issues by T. M. Ignatova

    Published 2012-07-01
    “…Tactics of early diagnostics, monitoring and active treatment of AE, and drug interactions prophylaxes increase safety and efficacy of treatment.…”
    Get full text
    Article